Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synbio TechROCO:1295 -0.40%44 PEG Ratio is 2.38 as of Jul. 17, 2026, which is 18% below its 10-year median of 2.92. GuruFocus rates ROCO:1295 with a GF Score™ of 44/100. The stock has 10 warning signs investors should review. Among 93 Biotechnology companies, Synbio Tech ranks worse than 60.22% on this metric.
PE Ratio without NRI / 5-Year EBITDA Growth Rate*
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Synbio Tech's PE Ratio without NRI is 9.53. Synbio Tech's 5-Year EBITDA growth rate is 4.00%. Therefore, Synbio Tech's PEG Ratio for today is 2.38.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Synbio Tech's PEG Ratio or its related term are showing as below:
ROCO:1295'
s PEG Ratio Range Over the Past 10 Years
Min: 2.21 Med: 2.92 Max: 4.05
Current: 2.38
During the past 6 years, Synbio Tech's highest PEG Ratio was 4.05. The lowest was 2.21. And the median was 2.92.
ROCO:1295's PEG Ratio is ranked worse than 60.22% of 93
companies
in the Biotechnology industry
Industry Median: 1.99
vs ROCO:1295: 2.38
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Synbio Tech (ROCO:1295) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Synbio Tech PEG Ratio Related Terms
Synbio Tech PEG Ratio Historical Data
* Premium members only.
The historical data trend for Synbio Tech's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:1295 vs VRTX, REGN, ALNY: PEG Ratio Comparison
For the Biotechnology subindustry, Synbio Tech's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synbio Tech PEG Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Synbio Tech's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Synbio Tech's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Synbio Tech (ROCO:1295) has a PEG Ratio of 2.38 as of Jul. 17, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Synbio Tech and its competitors. This is 18% below median its historical median of 2.92. Over the past decade, Synbio Tech's PEG Ratio has ranged from 2.21 to 4.05. According to the industry distribution chart, Synbio Tech ranks #56 out of 93 companies in the Biotechnology industry, placing it in the top 60.2%.
Is Synbio Tech's PEG Ratio too high?
Synbio Tech's current PEG Ratio of 2.38 is 18% below median its 10-year median of 2.92. Over the past 10 years, this metric has ranged from a low of 2.21 to a high of 4.05. The Biotechnology industry median PEG Ratio is 1.99. Synbio Tech's value of 2.38 is 19.6% above this industry median. Based on the distribution chart, Synbio Tech ranks #56 out of 93 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Synbio Tech has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Synbio Tech's PEG Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Synbio Tech ranks #56 out of 93 companies for PEG Ratio. This places Synbio Tech in the lower half of its industry. The industry median PEG Ratio is 1.99. Synbio Tech's value of 2.38 is 19.6% above this benchmark. Historically, Synbio Tech's own PEG Ratio has ranged from 2.21 to 4.05 over the past decade. While the company's 10-year median is 2.92 vs. the industry median of 1.99, Synbio Tech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Biotechnology company?
The median PEG Ratio among Biotechnology companies is 1.99, based on 93 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Synbio Tech's current PEG Ratio of 2.38 is 19.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Synbio Tech and its competitors. For the Biotechnology industry, the median PEG Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synbio Tech's current PEG Ratio is 2.38, which is 18% below median its own 10-year median of 2.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synbio Tech stock overvalued right now?
Synbio Tech (ROCO:1295) has a current PEG Ratio of 2.38. The current PEG Ratio is 2.38, which is 18% below median its 10-year median of 2.92 and 19.6% above the Biotechnology industry median of 1.99. Synbio Tech's overall GF Score™ is 44/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Synbio Tech (ROCO:1295), the current PEG Ratio is 2.38 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Synbio Tech Inc focus on functional research and manufacturing of probiotics for human health and economic animals. It has two reportable segments, Taiwan and Mainland China Segment to engage in the production and R&D technologies of the Taiwan Segment, including the production and sales of concentrated fermentation liquid, lactobacillus plantarum solid drinks, and lactobacillus plantarum granules for animal husbandry. It generates majority of revenue from Taiwan segment includes production and sale of lactobacillus plantarum powder, lactobacillus plantarum fermentation derivative products, probiotics dietary supplements, probiotics products for pets and economic animals, and probiotics products. It has presence in Taiwan, China, Southeast Asia, and Others.
44GF Score
Get the complete analysis for ROCO:1295
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1295 has been successfully added to your 
